Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications

Both obesity and diabetes are global health threats due to their high risk of developing different complications [...]

Bibliographic Details
Main Author:	Lu Cai
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Nutrients
Subjects:	n/a
Online Access:	https://www.mdpi.com/2072-6643/15/11/2515

Similar Items

Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
by: Jonas Cicenas, et al.
Published: (2021-02-01)

Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved
by: Gabriel Belfort, et al.
Published: (2023-04-01)

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus
by: Sphamandla E. Mtambo, et al.
Published: (2022-07-01)

Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
by: Jenna R. James, et al.
Published: (2023-02-01)

Novel anti-inflammatory activity of sunitinib malate identified in a macrophage drug-repurposing screen of FDA-approved medicines
by: Chaffey, L, et al.
Published: (2021)

Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study
by: Veera C. S. R. Chittepu, et al.
Published: (2019-05-01)

Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes
by: Lorenzo Flori, et al.
Published: (2023-04-01)

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
by: Dr. Chenshu Xu, et al.
Published: (2021-09-01)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
by: Devika Sirohi, et al.
Published: (2017-07-01)

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
by: Ashwini eBenedict, et al.
Published: (2015-07-01)

Redox Regulation of Metabolic Syndrome: From Biochemical Mechanisms to Nutritional Interventions
by: Mario Allegra
Published: (2021-04-01)

Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
by: Bin Li, et al.
Published: (2014-01-01)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
by: Jyothi Dhuguru, et al.
Published: (2022-01-01)

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
by: Emanuele Criscuolo, et al.
Published: (2023-12-01)

Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
by: Valentina L. Kouznetsova, et al.
Published: (2020-09-01)

Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
by: Matthew Cannon, et al.
Published: (2020-07-01)

Repurposing of FDA approved antibiotics as antimalarial agents: A network pharmacology based in silico approach
by: B. Gogoi, et al.
Published: (2020-12-01)

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
by: Zulfiqar Z, et al.
Published: (2020-12-01)

Renal Nutrition and Metabolism
by: Piergiorgio Messa
Published: (2022-05-01)

Special Issue: “Drug Repurposing for Cancer Therapies”
by: Cristina P. R. Xavier, et al.
Published: (2024-01-01)

Trends and Applications in Computationally Driven Drug Repurposing
by: Luca Pinzi, et al.
Published: (2023-11-01)

Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome
by: Mario Barbagallo, et al.
Published: (2022-02-01)

Editorial: Precision Medicine in Obstetrics: Pregnancy Complication
by: Serena Bertozzi, et al.
Published: (2023-02-01)

The Bittersweet Beat: Diabetes Complications
by: Joana Rossell, et al.
Published: (2023-06-01)

Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7)
by: Seema Zadi, et al.
Published: (2024-03-01)

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
by: Omima S. Mohammed, et al.
Published: (2023-11-01)

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
by: Pitchayathida Mee-udorn, et al.
Published: (2023-09-01)

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats [Retraction]
by: Zulfiqar Z, et al.
Published: (2022-11-01)

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
by: Alfred Olaoluwa Akinlalu, et al.
Published: (2021-09-01)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
by: Sergey Shityakov, et al.
Published: (2021-10-01)

Regenerative Medicine in Diabetes
by: Shoichiro Sumi
Published: (2020-11-01)

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
by: Jong H. Kim, et al.
Published: (2022-06-01)

Recent Advances in Nutrition and Diabetes
by: Omorogieva Ojo
Published: (2021-05-01)

Ocular Complications of Diabetes and Therapeutic Approaches
by: Pedro Romero-Aroca
Published: (2022-09-01)

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
by: Emanuele Pontali, et al.
Published: (2023-05-01)

Precision Bariatric/Metabolic Medicine and Surgery
by: Laurent Genser, et al.
Published: (2023-02-01)

Nutrition and Metabolism in the First 1000 Days of Life
by: Yalin Zhou, et al.
Published: (2023-05-01)

Dietary and Nutritional Guidelines for People with Diabetes
by: Katsumi Iizuka, et al.
Published: (2023-10-01)

Nutrition for Gestational Diabetes—Progress and Potential
by: Clive J. Petry
Published: (2020-09-01)

Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease.
by: Marcus M Ilg, et al.
Published: (2022-01-01)